Video
Dr. Humphrey discusses takeaways from NY GU 2022 in RCC/bladder cancer
Author(s):
Video Player is loading.
In this video, Peter A. Humphrey, MD, PhD, provides an overview of some important takeaways in bladder and kidney cancer that were discussed at the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies. Humphrey is a professor of pathology and the director of genitourinary pathology at the Yale University School of Medicine in New Haven, Connecticut.
Related Videos
Matthew Galsky, MD, reacts to NIAGARA results, durvalumab approval for MIBC
Sima Porten, MD, discusses the need to educate on the firefighter-bladder cancer link
Eugene Cone, MD, outlines potential impact of Expanded Access Program for rBCG
How recombinant BCG could ease strain of supply issues
Katherine Chan, MD, on viral vs non-viral vectors in bladder cancer
John Taylor, III, MD, on novel options in NMIBC
Suzanne B. Merrill, MD, FACS, on EAP program for recombinant BCG
What a long-term study of patients undergoing RARC reveals about upstaging
Sima Porten, MD, on the increased risk of bladder cancer among firefighters
Darren Feldman, MD, on study of 177Lu-girentuximab plus nivolumab for ccRCC
Related Content
